You are here

  • Home
  • Archive
  • Volume 12, Issue 9
  • Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study

Article info

Article menu

Download PDFPDF

Immunotherapy biomarkers
Original research
Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study

Authors

  • Guanchao Ye Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, ChinaDepartment of Thoracic Surgery, Huazhong University of Science and Technology Tongji Medical College Union Hospital, Wuhan, Hubei, China PubMed articlesGoogle scholar articles
  • Guangyao Wu Department of Radiology, Huazhong University of Science and Technology Tongji Medical College Union Hospital, Wuhan, Hubei, China PubMed articlesGoogle scholar articles
  • Yu Qi Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Kuo Li Department of Thoracic Surgery, Huazhong University of Science and Technology Tongji Medical College Union Hospital, Wuhan, Hubei, China PubMed articlesGoogle scholar articles
  • Mingliang Wang Department of Thoracic Surgery, Henan Provincial People's Hospital, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Chunyang Zhang Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Feng Li Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Leonard Wee Clinical Data Science, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The NetherlandsDepartment of Radiation Oncology (Maastro), GROW School of Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Andre Dekker Department of Radiation Oncology (Maastro), GROW School of Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Chu Han Department of Radiology, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangzhou, ChinaMedical Research Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Zaiyi Liu Department of Radiology, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangzhou, China PubMed articlesGoogle scholar articles
  • Yongde Liao Department of Thoracic Surgery, Huazhong University of Science and Technology Tongji Medical College Union Hospital, Wuhan, Hubei, China PubMed articlesGoogle scholar articles
  • Zhenwei Shi Department of Radiology, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangzhou, ChinaMedical Research Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China PubMed articlesGoogle scholar articles

Citation

Ye G, Wu G, Qi Y, et al
Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study
Journal for ImmunoTherapy of Cancer 2024;12:e009348. doi: 10.1136/jitc-2024-009348
Online issue publication 
September 03, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.